Reaction
Anal Stenosis reporting signals
As of the last recalculation, Anal Stenosis appears in 530 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is VEDOLIZUMAB (PRR 38.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vedolizumab | 73 | 38.4 | 38.5 |
| Meperidine Hydrochloride | 8 | 34.6 | 34.6 |
| Adalimumab-Fkjp | 35 | 31.7 | 31.7 |
| Isotretinoin | 37 | 31.5 | 31.5 |
| Adalimumab-Aaty | 35 | 31.0 | 31.0 |
| Adalimumab-Adaz | 38 | 30.4 | 30.4 |
| Teduglutide | 9 | 26.7 | 26.7 |
| Infliximab-Dyyb | 19 | 26.4 | 26.5 |
| Norepinephrine | 7 | 26.0 | 26.1 |
| Norepinephrine Bitartrate | 8 | 22.1 | 22.2 |
| Anakinra | 9 | 21.7 | 21.7 |
| Ustekinumab | 39 | 16.1 | 16.1 |